Delivery Order SPE2DB20D2104-SPE2DB23FU65U
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions, and has a ceiling value of $1,402.64. The contract has an ultimate completion date of December 16, 2024 and is a firm-fixed-price delivery order. This award is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions, with a ceiling value of $1,845.45. It is a firm-fixed-price contract with an ultimate completion date of August 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a prescription medication, with a ceiling value of $1,562.13 and a period of performance ending on May 5, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Repatha, a specialty medication used to treat cardiovascular conditions. The contract has a ceiling value of $1,331.22 and a period of performance through May 15, 2024. It is a firm fixed-price Delivery Order contract and was not set aside for any specific business type. The contract is likely part of a larger Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions, with a ceiling value of $4,687.38. The contract has a firm fixed price pricing type and an ultimate completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha, a prescription medication, with a firm fixed price of $1,672.53 and a completion date of June 25, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions. The delivery order is valued at $4,674.44 and has a completion date of June 22, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,742.10 firm fixed-price contract is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a completion date of July 10, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha, a specialty medication used to treat cardiovascular conditions. The $1,768.80 firm-fixed-price contract has a period of performance through November 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation. The contract, valued at $7,921.29, is for the supply of Repatha, a prescription medication used to treat certain types of high cholesterol. The contract has a firm fixed price and an ultimate completion date of August 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and is not subject to any set-aside...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU65UDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions. The contract has a ceiling value of $4,174.14 and an ultimate completion date of August 2, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/1/23 |